Breast Cancer Cells and Somatostatin
Author Information
Author(s): J. Nelson, M. Cremin, R.F. Murphy
Primary Institution: The Queen's University of Belfast
Hypothesis
Can somatostatin synthesized by breast cancer cells be inhibited by exogenous somatostatin and its analog Sandostatin?
Conclusion
The study confirms that somatostatin and Sandostatin inhibit the growth of certain breast cancer cell lines.
Supporting Evidence
- Somatostatin-like immunoreactivity was found in all three breast cancer cell lines.
- Continuous exposure to somatostatin or Sandostatin significantly inhibited cell proliferation.
- Short-term exposure to somatostatin had little effect on subsequent cell growth.
Takeaway
Breast cancer cells can make a substance called somatostatin, and giving them more of it can help slow their growth.
Methodology
The study involved culturing three breast cancer cell lines and testing the effects of somatostatin and Sandostatin on their growth.
Limitations
The study does not provide information on somatostatin levels in normal breast tissue.
Participant Demographics
Three human breast cancer cell lines: ZR-75-1, MDA-MB-436, and MCF-7.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website